SuperworthProcessa Pharmaceuticals EPS PCSA
Diluted earnings per share by quarter and over the last twelve months, from 2012.
- Last 12 months, to Jun 30, 2026
- −$5.74
- Latest quarter, Q2 FY26
- −$1.19
- Fiscal year 2025
- −$17.10
Processa Pharmaceuticals' earnings per share was −$5.74 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$1.19.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$17.10 | n/a |
| FY2024 | −$98.25 | n/a |
| FY2023 | −$218.00 | n/a |
| FY2022 | n/a | n/a |
| FY2021 | −$365.00 | n/a |
| FY2020 | −$785.00 | n/a |
| FY2019 | −$355.00 | n/a |
| FY2018 | −$350.00 | n/a |
| FY2017 | −$840.00 | n/a |
| FY2016 | −$665.00 | n/a |
| FY2015 | −$7595.00 | n/a |
| FY2014 | −$16170.00 | n/a |
| FY2013 | −$24745.00 | n/a |
| FY2012 | −$36995.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$1.19 | n/a | −$5.74 | |
| Q1 FY26 | −$1.29 | n/a | −$10.81 | |
| Q4 FY25 | −$1.51 | n/a | −$17.10 | |
| Q3 FY25 | −$1.75 | n/a | −$35.09 | |
| Q2 FY25 | −$6.26 | n/a | −$59.09 | |
| Q1 FY25 | −$7.58 | n/a | −$78.08 | |
| Q4 FY24 | −$19.50 | n/a | −$98.25 | |
| Q3 FY24 | −$25.75 | n/a | −$121.50 | |
| Q2 FY24 | −$25.25 | n/a | −$134.25 | |
| Q1 FY24 | −$27.75 | n/a | −$157.50 | |
| Q4 FY23 | −$42.75 | n/a | −$218.00 | |
| Q3 FY23 | −$38.50 | n/a | −$570.50 |
Against its peers
Companies in Healthcare nearest Processa Pharmaceuticals' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PCSAProcessa Pharmaceuticals | −$5.74 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Processa Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.